Marker Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.65

-0.01 (-0.60%)

As of Feb 8, 2:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +886.1% upside

Low Target $12.16

Average Target $16.27

High Target $21.27

Current Price $1.65

Current
$1.65

Target
$16.27

$12.16 $16.27 avg $21.27

Scenario Analysis

Bear Case

$12.16

637.0%

Low target

Base Case

$16.27

+886.1%

Avg target

Bull Case

$21.27

+1,189.1%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$19.48

-91.5% from high

52-Week Low

$10.45

+-84.2% from low

Target vs 52W High

$16.27

-16.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%